Cartiva synthetic cartilage implant lawsuit cases are growing rapidly in federal court. Hundreds of patients received this toe implant between 2016 and 2024. Many now face painful device failures requiring additional surgery. The Cartiva Synthetic Cartilage Implant was supposed to offer a better alternative to big toe joint fusion. However, studies reveal failure rates as high as 64%. As a result, Stryker Corporation recalled every Cartiva implant ever sold. Affected patients across the country are now filing claims seeking compensation for their injuries.
- What Is the Cartiva Synthetic Cartilage Implant Lawsuit About?
- MDL Case Status and Key Facts
- Who Qualifies for the Cartiva Synthetic Cartilage Implant Lawsuit?
- How to File a Cartiva Synthetic Cartilage Implant Lawsuit Claim
- Settlement Updates and What to Expect
- State-by-State Considerations
- Frequently Asked Questions
Case Timeline
Last checked: July 03, 2026
What Is the Cartiva Synthetic Cartilage Implant Lawsuit About?
| MDL Detail | Current Data |
|---|---|
| MDL Number | MDL-3172 |
| Pending Cases | 21 |
| Presiding Judge | TBD |
| Federal District | TBD |
| Data Source | U.S. Judicial Panel on Multidistrict Litigation |
| Last Updated | July 06, 2026 |
The cartiva synthetic cartilage implant lawsuit centers on a defective medical device. Cartiva, Inc. developed the Cartiva SCI as a polyvinyl alcohol (PVA) hydrogel implant. It was designed to replace damaged cartilage in the big toe joint. The FDA granted Premarket Approval (PMA P150017) on July 1, 2016. It was the first hydrogel polymer implant ever approved to replace a joint surface. Doctors used it to treat hallux rigidus, a form of big toe arthritis.
Wright Medical Group acquired Cartiva, Inc. in October 2018. Stryker Corporation then acquired Wright Medical in November 2020. Plaintiffs allege all three companies knew the implant failed at rates far higher than disclosed. The original clinical trial reported roughly 13% failure. However, independent research published in Foot and Ankle Surgery in October 2024 found failure rates closer to 64%. That means approximately two out of three patients experienced implant failure.
Injuries linked to the device include implant fragmentation, subsidence, and displacement. Patients also report foreign body reactions, osteolysis, bone cyst formation, and nerve damage. In most cases, failed implants require removal followed by joint fusion surgery. This is the very procedure the Cartiva implant was designed to avoid. As a result, patients endure multiple surgeries, extended recovery, and lasting disability.
MDL Case Status and Key Facts
| Detail | Information |
|---|---|
| MDL Number | 3172 |
| Full Title | In re: Cartiva Synthetic Cartilage Implant Products Liability Litigation |
| Master Docket | 4:26-md-03172-KGB |
| Presiding Judge | Kristine G. Baker |
| Federal District | Eastern District of Arkansas |
| MDL Created | February 5, 2026 |
| Approximate Case Count | 100+ |
| Bellwether Trials | Not yet scheduled under MDL; expected late 2026 or 2027 |
| Defendants | Stryker Corporation, Wright Medical Group N.V., Cartiva, Inc. |
The Judicial Panel on Multidistrict Litigation (JPML) centralized all federal cartiva synthetic cartilage implant lawsuit cases on February 5, 2026. The panel heard oral arguments on January 29, 2026. Five pending actions were initially transferred. Nine additional tag-along actions from seven federal districts followed. The JPML selected the Eastern District of Arkansas due to its proximity to Wright Medical’s former headquarters in Memphis, Tennessee.
As of June 2026, the MDL is in its early organizational phase. Judge Baker is establishing pretrial procedures and discovery schedules. No bellwether trials have been completed yet. The case count continues to grow as new plaintiffs file claims. Typically, MDL case counts increase significantly during the first year after centralization.
Who Qualifies for the Cartiva Synthetic Cartilage Implant Lawsuit?
You may qualify for the cartiva synthetic cartilage implant lawsuit if you received a Cartiva SCI device. The implant was distributed nationwide from July 2016 through October 2024. Stryker recalled all model numbers: CAR-06-US, CAR-08-US, CAR-10-US, and CAR-12-US. Every lot ever manufactured is included in the FDA Class II recall.
Qualifying injuries typically include implant failure requiring revision surgery. Other qualifying conditions include implant fragmentation, subsidence, migration, or displacement. Persistent pain worse than before surgery also qualifies. For example, bone cyst formation, osteolysis, foreign body reaction, and nerve damage are all recognized injuries in this litigation. You do not need to have undergone revision surgery yet to file a claim.
Key evidence includes your surgical records showing Cartiva implant placement. Medical imaging documenting device failure or bone damage strengthens your case. Records of revision surgery or recommendations for additional procedures are also important. However, you should consult a licensed attorney to evaluate your specific situation. Each cartiva synthetic cartilage implant lawsuit claim depends on individual medical facts and applicable state law.
How to File a Cartiva Synthetic Cartilage Implant Lawsuit Claim
Filing a cartiva synthetic cartilage implant lawsuit starts with contacting a qualified attorney. Look for a law firm experienced in medical device litigation and MDL cases. Most firms handling these cases offer free consultations. They typically work on a contingency fee basis. This means you pay nothing upfront and no fees unless you recover compensation.
Your attorney will gather your medical records and surgical history. They will file your case in the appropriate court. Federal cases are transferred to MDL-3172 in the Eastern District of Arkansas. You will likely need to complete a Plaintiff Fact Sheet. This document provides the court with details about your implant, injuries, and medical treatment. Your attorney handles most of this paperwork on your behalf.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
The statute of limitations varies by state. In most cases, the clock starts when you discovered or should have discovered the injury. The October 2024 recall is a key date for many plaintiffs. However, some states have shorter filing deadlines. For example, states like Tennessee and Alabama have stricter limitations periods. Do not delay in consulting an attorney. Waiting too long could bar your cartiva synthetic cartilage implant lawsuit claim entirely.
Settlement Updates and What to Expect
No global settlement has been announced in the cartiva synthetic cartilage implant lawsuit as of June 2026. The MDL is still in its early stages. Discovery and pretrial proceedings must occur before settlement talks typically begin. However, reports indicate Stryker has settled some individual cases privately. The terms of those settlements remain confidential.
Bellwether trials are expected to be scheduled as the MDL progresses. These test cases help both sides evaluate the strength of claims. Bellwether outcomes often influence global settlement negotiations. Typically, MDL settlements in medical device cases take two to four years after centralization. Several factors affect potential compensation amounts.
Key factors include the severity of your injury and number of revision surgeries. Lost wages, medical expenses, and impact on daily life also matter. Whether the implant fragmented or caused bone destruction may increase claim value. Settlement amounts in medical device MDLs vary widely based on individual circumstances. A licensed attorney can help estimate the potential value of your specific cartiva synthetic cartilage implant lawsuit claim.
State-by-State Considerations
State tort reform laws significantly affect each cartiva synthetic cartilage implant lawsuit claim. Each state sets its own statute of limitations, damage caps, and liability standards. For example, Kentucky and West Virginia appear to have high concentrations of plaintiffs. Pennsylvania, North Carolina, and Maryland also have notable filing activity. Some states cap non-economic damages, which can limit total compensation. Others have joint-and-several liability rules that affect how defendants share responsibility.
Understanding your state’s laws is critical. A cartiva synthetic cartilage implant lawsuit filed in a state with favorable plaintiff protections may yield different results than one filed in a tort-reform state. Check our state-by-state tort reform guide to understand how your state’s rules may affect your claim. Consulting a licensed attorney familiar with your state’s medical device laws is strongly recommended.
Frequently Asked Questions
Is it too late to file a cartiva synthetic cartilage implant lawsuit?
For most patients, it is not too late. The Stryker recall occurred in October 2024. Many states apply a discovery rule that starts the clock when you learned about the defect. However, filing deadlines vary by state. Consult an attorney promptly to protect your rights.
Do I need to have had revision surgery to qualify?
No. You do not need revision surgery to file a cartiva synthetic cartilage implant lawsuit claim. Documented implant failure, persistent pain, or imaging showing device problems may be sufficient. However, patients who underwent revision surgery typically have stronger claims with higher potential compensation.
How long will the MDL take to resolve?
Medical device MDLs typically take several years to reach resolution. MDL-3172 was created in February 2026 and is still in its early stages. Bellwether trials and settlement negotiations will follow discovery. Most plaintiffs should expect a timeline of two to four years. Your attorney can provide updates specific to your case as proceedings advance.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- U.S. Judicial Panel on Multidistrict Litigation (JPML)
- U.S. Department of Justice
- FDA Safety Alerts & Recalls
- Centers for Disease Control and Prevention
- U.S. Environmental Protection Agency
Content last reviewed June 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Georgia Tort Reform Guide
- Pennsylvania Tort Reform Guide
- New York Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.